July 10, 2020
Economic downturns and catastrophic events can often prompt market consolidation, so perhaps it's no great surprise that the first half of 2020 has been unusually active when it comes to mergers and acquisitions, especially in the second quarter.
MobiHealthNews tracked 23 confirmed acquisitions in Q2, plus one credibly reported one, and another 11 in Q1, for 35 so far this year – six up from last...
November 20, 2019
Sanofi is merging its real-world data platform with New York startup Aetion’s similar evidence platform to augment its treatment development and deployment efforts, the companies announced today. Sanofi’s DARWIN platform will provide a substantial body of de-identified patient data, which the Aetion Evidence Platform will analyze those information for insights on drug effectiveness, safety and...
November 15, 2019
The increased spotlight on Google’s healthcare privacy practices doesn’t seem to be letting up, with the Washington Post publishing a story this morning detailing a botched arrangement between the tech giant and the National Institutes of Health back in 2017.
The two groups had a research arrangement centered on more than 100,000 chest X-ray images provided to Google by the NIH. However,...
July 31, 2019
Litmus Health announced yesterday the release of a new version of its device-friendly clinical research platform for the collection and analysis of real-world data.
Built with new features to help pharmaceutical companies from the beginning to the end of their drug trials, the platform now adds Actigraph’s medical-grade wearables to its repertoire of supported devices, which previously included...
May 28, 2019
Microsoft recently detailed two partnerships with pediatric health research groups that have yielded tools and insights for clinicians tackling prevalent conditions.
The first, with Seattle Children’s Research Institute, saw the two organizations teaming up on a data-driven partnership aiming to identify predictors and risk factors for sudden infant death syndrome (SIDS). By collecting public...
December 12, 2018
This morning, Garmin and medical-grade monitor maker ActiGraph announced a new partnership that will focus on wearables for medical research and patient care.
Specifically, the pair will be applying ActiGraph’s CentrePoint data analytics platform to Garmin’s consumer-grade wearables. CentrePoint is a web-based, cloud-enabled service offering automated activity monitor assignments, data...
April 12, 2018
ActiGraph activity monitors and a mobile app from Clinical Ink are are at the heart of a newly announced pilot study backed by Bayer, according to a statement released today by ActiGraph. The ongoing study is evaluating how these digital products and a Bluetooth-enabled weight scale are perceived by patients, and the feasibility of implementing such devices in future clinical trials run by the...
April 27, 2017
New York-based Fit4D, which offers digital coaching for people with diabetes, is partnering with global diabetes data management company Glooko to bring a more data-driven approach to their mobile patient engagement tools. The pairing will give Fit4D’s coaches access to Glooko’s device-agnostic platform, which people with diabetes see in the form of a mobile app they can use to automatically sync...
October 26, 2015
The National Institute of Diabetes and Digestive Kidney Diseases (NIDDK), which is part of the National Institutes of Health (NIH), has awarded Providence's Miriam Hospital and Boston's Beth Israel Deaconess Medical Center a $1.3 million grant so that researchers can conduct a mobile-enabled study to research weight loss after bariatric surgery.
The researchers will begin recruiting participants...
November 17, 2014
Pharmaceutical company GlaxoSmithKline is using mobile health tools in a small study -- just six subjects -- that could lead to there more widespread use in clinical trials. The company is working with data startup Medidata and sensor makers Vital Connect and ActiGraph to evaluate the impact of wearable sensors in clinical trial settings.
“Working with GSK on this initiative has provided us with...